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The metabolic syndrome is characterized by a 
cluster of physiological alterations including 
glucose intolerance/insulin resistance, abdomi-
nal obesity, atherogenic dyslipidemia (low con-
centration of plasma high-density lipoprotein 
cholesterol and high concentration of plasma 
triglycerides), and elevated blood pressure. Oc-
curring together, these conditions increase the 
risk for atherosclerosis and type 2 diabetes melli-
tus, which are typical obesity-associated diseases 
that are endemic in developed countries, cur-
rently affecting 25% of the population and grow-
ing (McCullough, 2011). Recent investigations 
have increasingly shown that low-grade systemic 
inflammation is often associated with metabolic 
syndrome, which probably plays a critical role 
in the development of these metabolic diseases 
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Low-grade systemic inflammation is often associated with metabolic syndrome, which plays 
a critical role in the development of the obesity-associated inflammatory diseases, includ-
ing insulin resistance and atherosclerosis. Here, we investigate how Toll-like receptor–
MyD88 signaling in myeloid and endothelial cells coordinately participates in the initiation 
and progression of high fat diet–induced systemic inflammation and metabolic inflamma-
tory diseases. MyD88 deficiency in myeloid cells inhibits macrophage recruitment to adi-
pose tissue and their switch to an M1-like phenotype. This is accompanied by substantially 
reduced diet-induced systemic inflammation, insulin resistance, and atherosclerosis. MyD88 
deficiency in endothelial cells results in a moderate reduction in diet-induced adipose 
macrophage infiltration and M1 polarization, selective insulin sensitivity in adipose tissue, 
and amelioration of spontaneous atherosclerosis. Both in vivo and ex vivo studies suggest 
that MyD88-dependent GM-CSF production from the endothelial cells might play a critical 
role in the initiation of obesity-associated inflammation and development of atherosclerosis 
by priming the monocytes in the adipose and arterial tissues to differentiate into M1-like 
inflammatory macrophages. Collectively, these results implicate a critical MyD88-dependent 
interplay between myeloid and endothelial cells in the initiation and progression of obesity-
associated inflammatory diseases.
© 2014 Yu et al. This article is distributed under the terms of an Attribution– 
Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.rupress.org/terms). After six months 
it is available under a Creative Commons License (Attribution–Noncommercial– 
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inflammatory diseases. The cell type–specific MyD88/ mice 
are crucial, as complete MyD88/ mice (1) are immune com-
promised and prone to infection; (2) do not adequately reflect 
specific role of MyD88 in different cell types (Subramanian 
et al., 2013). Indeed, several previous studies using complete 
MyD88/ mice produced conflicting results regarding the 
role of MyD88 in obesity-associated inflammatory diseases, 
which might be due to the immune deficiency of complete 
MyD88/ mice and the housing environment in different 
institutions (Björkbacka et al., 2004; Michelsen et al., 2004; 
Hosoi et al., 2010). Therefore, studies using cell type–specific 
MyD88/ mice are necessary and timely to elucidate the 
mechanistic role of TLR-MyD88 signaling in obesity-associated 
inflammatory diseases.
Using cell type–specific MyD88-deficient mice, our find-
ings for the first time demonstrate the MyD88-dependent 
cooperative actions of myeloid and endothelial cells in the de-
velopment and progression of metabolic inflammatory diseases. 
MyD88 deficiency in myeloid cells (MyD88MC-KO) substan-
tially reduced diet-induced systemic inflammation, insulin re-
sistance, and atherosclerosis. Furthermore, deletion of MyD88 
in myeloid cells prevented macrophage infiltration into adipose 
tissue and aborted a switch in adipose tissue macrophage (ATM) 
phenotype from M2-like to M1-like. Using an adipocyte-
macrophage ex vivo co-culture system and adipocyte-derived 
endogenous TLR ligand FFA, we demonstrated the influence 
of adipocytes on MyD88-dependent induction of M1-associated 
genes in macrophages, indicating the cross-talk between adipo-
cytes and macrophages. On the other hand, MyD88 deficiency 
in endothelial cells (MyD88EC-KO) showed moderate reduction 
in diet-induced adipose M1-like macrophages with selective 
insulin sensitivity in adipose tissue, and amelioration of sponta-
neous atherosclerosis. Both in vivo and ex vivo studies suggest 
that MyD88-dependent GM-CSF production from the endo-
thelial cells might play a critical role in the initiation of obesity-
associated inflammation and development of atherosclerosis 
by priming the monocytes in the adipose and arterial tissues to 
M1-like inflammatory macrophages. Collectively, these results 
implicate a critical MyD88-dependent interplay among adipo-
cytes, macrophages, and endothelial cells in the initiation of diet-
induced systemic inflammatory state and metabolic diseases.
RESULTS
Generation of myeloid- and endothelial  
cell–specific MyD88-deficient mice
Endothelial cell–specific MyD88-deficient mice created by 
cre-lox technology were validated by PCR (Fig. 1 A) and 
Western-blot analysis (not depicted). Tie2eCre transgenic 
mice (generated using the Tie2 5 promoter and first intron 
enhancer element) express Cre within endothelium of brain, 
heart, and liver, among others (Kano et al., 2003; Kang et al., 
2010). It is important to note that Tie2eCre (distinct from 
Tie2Cre) is restricted to endothelium, and Cre expression is 
minimally leaky (Kano et al., 2003; Kang et al., 2010). MyD88 
expression was abolished in CD31+ endothelial cells from the 
(Hirosumi et al., 2002; Zieske et al., 2005; Hotamisligil, 2006; 
Wärnberg et al., 2006). Previous studies have shown that a 
high-fat diet (HFD) can increase the gut permeability, trigger-
ing the accumulation of systemic inflammatory stimuli (Erridge, 
2011), including pathogen-associated molecular patterns, such 
as ligands for TLRs, endogenous TLR ligands such as fatty 
acids and inflammatory cytokines, including IL-1 (Shi et al., 
2006; Cani et al., 2007; Creely et al., 2007; Cani et al., 2008; 
Holvoet et al., 2008; Dasu et al., 2012). Although inflammation 
is generally considered to be a localized reaction, it is now 
understood that a systemic inflammatory response can occur 
when inflammatory stimuli gain access to the circulation 
(Hotamisligil, 2006).
Genetic studies and mouse disease models have shown the 
participation of TLR and IL-1R in the development of HFD-
induced systemic inflammation and obesity-associated inflam-
matory diseases. TLR4 deficiency reduced diet-induced insulin 
resistance and systemic inflammation (Shi et al., 2006), whereas 
TLR2-deficient mice were partially protected from diet-
induced obesity (Himes and Smith, 2010). Human TLR4-null 
mutations are associated with reduced risk of atherosclerosis 
(Kiechl et al., 2002). ApoE/ mice, a commonly used model, 
spontaneously develop atherosclerosis; deficiency in TLR4, 
IL-1, and IL-1R each reduced vascular inflammation and ath-
erosclerosis in ApoE/ mice (Kirii et al., 2003; Björkbacka et al., 
2004; Chi et al., 2004; Michelsen et al., 2004). These previous 
studies suggested that exogenous/endogenous TLR ligands 
and the proinflammatory cytokine IL-1 can activate IL-1R/
TLRs in multiple tissues, including adipose, liver, pancreas, 
aorta, heart, and muscle. As a consequence, a chronic systemic 
inflammatory response is established, which is strongly associ-
ated with the development of type II diabetes and atheroscle-
rosis (Erridge, 2011; Fresno et al., 2011; Könner and Brüning, 
2011). Much effort has been devoted toward the understand-
ing of IL-1R/TLR-mediated signaling mechanisms, with the 
long-term objective to identify new therapeutic targets and de-
velop more effective antiinflammatory small molecule drugs. 
Upon ligand stimulation, IL-1R and TLRs form either homo- 
or hetero-oligomers. The adapter molecule MyD88 is recruited 
to all IL-1R/TLR oligomers, with the exception of TLR3, 
followed by the recruitment of the serine/threonine IL-1 re-
ceptor kinases (IRAKs; Takeuchi and Akira, 2002; Kenny and 
O’Neill, 2008; Lin et al., 2010; Brown et al., 2011; Gay et al., 
2011). Genetic and biochemical studies revealed that through 
activation of MyD88-IRAKs, downstream kinases are orga-
nized by multiple adapter molecules into parallel and sequential 
signaling cascades, leading to activation of the transcription fac-
tor NF-B and mitogen-activated protein kinases (Kim et al., 
2007; Yao et al., 2007; Fraczek et al., 2008), resulting in the pro-
duction of inflammatory cytokines and chemokines.
Although TLR-MyD88 signaling has been implicated in 
obesity-associated inflammatory diseases, the molecular and 
cellular mechanisms are not completely understood. In this 
study, we investigated how TLR-MyD88 signaling in different 
cellular compartments coordinately participates in the initia-
tion of HFD-induced systemic inflammation and metabolic 
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aortas of Tie2eCreMyD88fl/fl (MyD88EC-KO) mice compared 
with control (Tie2eCreMyD88fl/+, Con EC-KO), but showed 
normal MyD88 expression in monocytes (Fig. 1 A). To generate 
myeloid-specific MyD88-deficient mice, we used CD11bCre 
transgenic mice (generated with the promoter for CD11b, 
an integrin expressed exclusively in the myeloid lineage; 
Boillée et al., 2006; Kang et al., 2010; Kang et al., 2012). These 
mice express Cre in macrophages, microglia, and activated 
liver Kupffer cells. CD11bCreMyD88fl/+ mice were bred to 
MyD88fl/fl to generate control mice (CD11bCreMyD88fl/+, 
ConMC-KO) and myeloid-specific MyD88-deficient mice 
(CD11bCreMyD88fl/fl, MyD88MC-KO). PCR analysis showed 
that MyD88 expression was diminished in CD11b+ mono-
cytes derived from CD11bCreMyD88fl/fl (MyD88MC-KO) 
mice compared with that in ConMC-KO mice (Fig. 1 A).
MyD88 deficiency in myeloid and endothelial cells  
reduce diet-induced insulin resistance
We first analyzed metabolic parameters of MyD88MC-KO and 
MyD88EC-KO mice on chow diet or HFD. There were no sub-
stantial differences in weight gain over the course of 20 wk 
(Fig. 1, B and C) with similar levels of serum cholesterol, tri-
glycerides, and nonesterified fatty acids (not depicted) in 
MyD88MC-KO and MyD88EC-KO mice fed on chow or HFD 
compared with their respective littermate controls. These re-
sults indicate that MyD88 deficiency in endothelial or myeloid 
cells did not affect diet-induced weight gain and lipid homeosta-
sis. We then examined glucose metabolism in the MyD88MC-KO 
and MyD88EC-KO mice. Interestingly, after HFD (for 6 wk and 
3 mo), fasting glucose and fasting insulin levels were substan-
tially decreased in MyD88MC-KO mice compared with the lit-
termate controls (Fig. 1, D and E). By performing a glucose 
tolerance test (GTT), we found that HFD-fed MyD88MC-KO 
mice had much improved glucose tolerance compared with the 
littermate controls (Fig. 2, A and B). Endothelial MyD88 defi-
ciency also improved insulin sensitivity, but the impact was more 
dramatic at early phase (6 wk) compared with that after 3 mo of 
HFD (Fig. 2, C and D). As controls, we noticed that the glucose 
tolerance and insulin sensitivity in chow diet–fed MyD88MC-KO 
and MyD88EC-KO mice were comparable with their respective 
littermate controls (Fig. 1, D and E; and not depicted).
Deletion of MyD88 in myeloid cells and endothelial cells 
preserves insulin signaling in different tissues
Because MyD88 deficiency in myeloid and endothelial cells 
attenuated diet-induced insulin resistance, we next examined 
insulin sensitivity in several tissues (including adipose tissue, 
muscle, and liver) by i.p. injecting HFD-fed mice with insulin 
or saline after an overnight fast. As expected, compared with 
normal chow-fed mice, insulin-induced AKT phosphorylation, 
tyrosine phosphorylation of IRS1 (insulin receptor substrate 1), 
and IRS1 interaction with p85-phosphoinositide 3 kinase 
(PI3K) were greatly reduced in adipose tissue, liver, and muscle 
of HFD-fed wild-type control mice (Fig. 3, A–D), demonstrat-
ing diet-induced insulin insensitivity of these tissues. Interest-
ingly, although insulin-induced AKT phosphorylation was 
Figure 1. MyD88 deficiency in myeloid and endothelial cells 
improves diet-induced hyperglycemia and hyperinsulinemia.  
(A) PCR for MyD88 mRNA of mouse CD11b+ splenic monocytes 
(CD11b+ monocytes) and CD31+ primary aortic vascular endothelial 
cells (MAVECs) from MyD88EC-KO, MyD88MC-KO and their respective lit-
termate controls (ConMC-KO and ConEC-KO). Data are presented as mean ± 
SD based on 5–7 for each group and are representative of three  
independent experiments. Body weights of (B) MyD88MC-KO or (C) 
MyD88EC-KO male mice and their littermate controls (maintained on a 
chow diet or HFD) were measured weekly from 6–26 wk of age.  
(D) Serum fasting glucose and (E) fasting insulin levels were measured 
in MyD88MC-KO, MyD88EC-KO male mice and their respective littermate 
controls fed on chow diet (6 mo of age) or HFD (for 6 wk or 3 mo 
starting from 6 wk of age). n = 9–11 mice per genotype. Data are rep-
resentative of two independent experiments. *, P < 0.05.
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MyD88MC-KOApoE/, MyD88EC-KOApoE/ mice and con-
trol mice (ConMC-KOApoE/ and ConEC-KOApoE/ mice). 
Total plasma cholesterol levels and cholesterol distribution 
were similar among 18-wk-old female MyD88MC-KO ApoE/, 
MyD88EC-KO ApoE/ and their respective littermate controls 
either on chow diet or HFD (unpublished data).
We first compared the severity of atherosclerosis in chow-
fed MyD88MC-KOApoE/, MyD88EC-KOApoE/ and their 
respective littermate controls at 18 wk of age. En face and 
aortic root section analysis of atherosclerotic lesions showed 
60–70% reduction in both MyD88MC-KO ApoE/ and 
MyD88EC-KO ApoE/ mice compared with littermate con-
trols (Fig. 4, A–D). Thus, MyD88 deficiency in endothelial or 
myeloid cells inhibited vascular lesion formation in this model 
of spontaneous atherosclerosis. Consistently, under chow diet 
MyD88 deficiency in myeloid or endothelial cells had similar 
impact on insulin sensitivity of aortas compared with that in 
their littermate controls (Fig. 4 E). We next examined expression 
of inflammatory genes in arterial tissue of both MyD88MC-KO 
ApoE/ and MyD88EC-KOApoE/mice. The expression 
levels of M-CSF, MCP-1, iNOS, VCAM-1, ICAM-1, and es-
pecially GM-CSF, were substantially reduced in the arterial tis-
sue of MyD88 EC-KOApoE/mice, whereas TNF, IL-6 and 
IL-1 were similarly decreased in arterial tissue of MyD88EC-KO 
ApoE/ and MyD88MC-KOApoE/ mice compared with 
that of littermate controls (Fig. 5, A and B).
Because it is well known that the pathology of atheroscle-
rosis in ApoE/ mice is further aggravated upon HFD feeding, 
preserved in all three tissues of HFD-fed MyD88MC-KO mice, 
endothelial-specific MyD88 deficiency only rescued insulin 
signaling substantially in adipose tissue(Fig. 3, E–H). Consis-
tently, insulin-induced IRS-1 tyrosine phosphorylation and its 
association with PI3K (p85) were preserved in adipose tissue, 
liver, and muscle of HFD-fed MyD88MC-KO mice, but only re-
stored in adipose tissue of HFD-fed MyD88EC-KO mice, com-
pared with that in their respective HFD-fed littermate controls 
(Fig. 3, E–H). Thus, endothelial-derived MyD88 plays a more 
important role in HFD-induced insulin resistance in the adi-
pose tissue than that in liver and muscle.
Myeloid- and endothelial-specific MyD88 deficiency  
protect mice from atherosclerosis in ApoE/ mice
Atherosclerosis is a chronic inflammatory disease of the arteries, 
representing the underlying cause of the majority of cardiovas-
cular disease. Obesity is an independent risk factor for the de-
velopment of cardiovascular atherosclerosis. Obesity-induced 
insulin resistance and impaired glucose metabolism can exacer-
bate atherosclerosis. To study the impact of MyD88 deficiency 
in endothelial or myeloid cells on the pathogenesis of ath-
erosclerosis, we used the ApoE-deficient mice, which spon-
taneously develop hypercholesterolemia and atherosclerosis. 
Because female ApoE/ mice were shown to develop a more 
severe phenotype than male ApoE/(Caligiuri et al., 1999; 
Smith et al., 2010), we decided to use the female mice in this 
model. MyD88MC-KO, MyD88EC-KO mice, and respective lit-
termate controls were crossed to ApoE/ mice to generate 
Figure 2. Deletion of MyD88 in myeloid cells and endothelial cells reduces diet-induced insulin resistance. GTTs in MyD88MC-KO male mice and 
littermate controls on HFD for (A) 6 wk or (B) 3 mo starting from 6-wk-old (6-mo-old mice on chow diet as controls, data not shown). Area under curve 
(AUC) was calculated. GTT in MyD88EC-KO mice and their littermate controls on HFD for (C) 6 wk or (D) 3 mo starting from 6 wk of age (6-mo-old mice on 
chow diet as controls, data not shown). AUC was calculated. Data are presented as mean ± SEM (n = 9–11 mice per genotype) and are representative of 
two independent experiments. *, P < 0.05; **, P < 0.01.
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controls (Fig. 5, C and D). On the other hand, the expression of 
several inflammatory genes (M-CSF, MCP-1, iNOS, VCAM-1, 
and ICAM-1) was equally decreased in arterial tissue of 
MyD88MC-KO ApoE/ and MyD88EC-KOApoE/mice com-
pared with littermate controls (Fig. 5, C and D). It is important 
to note that the expression of GM-CSF was more dramatically 
decreased in arterial tissue of MyD88EC-KO ApoE/ than that 
in MyD88MC-KOApoE/mice compared with that in litter-
mate controls (Fig. 5, C and D). Lastly, through the analysis of 
gene expression in aorta, we did notice that the expression of 
Arg1 and IL-10 were always enhanced in the arterial tissue 
of either chow- or HFD-fed MyD88EC-KO ApoE/ and 
MyD88MC-KOApoE/ mice compared with that in their re-
spective littermate controls (Fig. 5, A–D), which will be further 
discussed below.
we then compared diet-induced atherosclerotic lesions of 
the endothelial- and myeloid-specific MyD88-deficient mice 
with their littermate controls. En face and aortic root sec-
tion analysis of atherosclerotic lesions showed 70% versus 
40% reduction, respectively, in lesion areas of MyD88MC-KO 
ApoE/ mice and MyD88EC-KO ApoE/ mice compared 
with their littermate controls (Fig. 4, A–D). It is important to 
note that HFD substantially induced insulin resistance in the 
aortas of wild-type control mice. Both MyD88MC-KO ApoE/ 
and MyD88EC-KO ApoE/ mice showed improved insulin 
sensitivity of aortas compared with their littermate controls 
(Fig. 4 E). The expression of inflammatory genes (CXCL1, 
TNF, IL-6, and IL-1) was more dramatically decreased in ar-
terial tissue of MyD88MC-KO ApoE/ than that in MyD88EC-KO 
ApoE/mice compared with their respective littermate 
Figure 3. Deletion of MyD88 in myeloid cells and endothelial cells preserves insulin signaling. After overnight fast, 5-mo-old control group 
(CD11bCreMyD88fl/+ and Tie2eCreMyD88fl/+) male mice kept on chow diet or HFD were injected with either saline () or 25 mU/kg of insulin (+). (A) White 
adipose tissues (WAT), (B) muscles, and (C) livers were collected 5 min later. (E) WAT, (F) muscles, and (G) livers of MyD88MC-KO, MyD88EC-KO, and control 
group male mice kept on HFD for 3 mo were collected at 5 min after saline or insulin injection. Protein extracts were prepared, immunoprecipitated with 
anti-IRS-1, followed by Western blot analysis with antibodies for phosphotyrosine (PY20, pY) or p85-PI3K. The levels of IRS1, activated AKT (pSer473, 
pAKT) and total AKT, were determined by immunoblotting of the original lysates. (D and H) The levels of pAKT and AKT were quantified by densitometry. 
The ratio of pAKT to AKT was expressed as a mean ± SEM (*, P < 0.05; **, P < 0.01). n = 4 mice per genotype. The results are representative of three inde-
pendent experiments.
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Figure 4. Myeloid- and endothelial-specific MyD88 deficiency protect mice from atherosclerosis. (A) MyD88MC-KO ApoE/ and (B) MyD88EC-KO 
ApoE/ female mice and their respective littermate controls (ConMC-KO ApoE/ and ConEC-KO ApoE/), were fed on chow diet or HFD for 12 wk begin-
ning at 6 wk of age. Enface (oil red O staining) analysis was done for the whole aorta tree from end of the curvature of the aortic arch to the iliac bifurca-
tion from these mice. Total mean lesion area was quantified based on image-analysis (Photoshop; Adobe). Data are presented as mean ± SEM (n = 9–12 
mice per genotype) and are representative of two independent experiments. *, P < 0.05; **, P < 0.01. Cross-sections of aortic roots from (C) MyD88MC-KO 
ApoE/ and (D) MyD88EC-KO ApoE/ female mice and their respective littermate controls fed on chow diet or HFD for 12 wk were stained with oil red O 
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were greatly reduced in MyD88MC-KO mice (Fig. 5 E). On the 
other hand, the deletion of MyD88 in endothelial cells only 
moderately reduced serum levels of these proinflammatory 
cytokines (Fig. 5 E). As shown in Fig. 4 (A–D), myeloid MyD88 
also plays a more critical role than endothelial MyD88 in 
HFD-induced atherosclerosis, suggesting that systemic in-
flammation might contribute to HFD-induced exacerbation 
on atherosclerosis. Under systemic inflammation, in addition 
to ox-LDL and IL-1, the endothelium is probably also acti-
vated by other circulating inflammatory stimuli through 
MyD88-independent pathways, including TNF and IL-6 (Aird, 
2007). Collectively, our results suggest that whereas both my-
eloid and endothelial MyD88 participate in the initiation of 
Myeloid-derived MyD88 is required  
for HFD-induced systemic inflammation
Recent studies have shown a direct link between “chronic 
systemic inflammation” and diet-induced metabolic syndrome 
and consequent obesity-associated inflammatory diseases (Elhage 
et al., 1998; Huber et al., 1999; Cheung et al., 2000; Klover et al., 
2003; Plomgaard et al., 2005; Hotamisligil, 2006; De Taeye et al., 
2007; Dixon and Symmons, 2007; Avouac and Allanore, 2008; 
Kleemann et al., 2008; Ehses et al., 2009; Ferrante et al., 2009; 
Monteiro and Azevedo, 2010; Emanuela et al., 2012). Low-grade 
inflammation triggered by the HFD was indeed detected in 
the circulation of control mice, whereas diet-induced serum 
proinflammatory cytokines (IL-1, IL-6, TNF, and CXCL1) 
(bar, 250 µm). Total mean lesion area was quantified by Photoshop software and shown as mean ± SEM and are representative of three independent 
experiments. *, P < 0.05; **, P < 0.01. n = 6–7 mice per genotype. (E) Aortas of MyD88MC-KO ApoE/, MyD88EC-KO ApoE/, and control group female mice 
kept on either chow diet or HFD for 3 mo were collected at 5 min after saline or insulin injection. Protein extracts were analyzed as described in Fig. 2 (A–D). 
The levels of pAKT and AKT were quantified by densitometry. The ratio of pAKT to AKT was expressed as a mean ± SEM. *, P < 0.05; **, P < 0.01. n = 4 mice 
per genotype. The results are representative of three independent experiments.
 
Figure 5. MyD88 deficiency in myeloid and 
endothelial cells ameliorates arterial tissue 
inflammation under hypercholesterolemia and 
diet-induced systemic inflammation. Total 
RNA of aortas was isolated from MyD88MC-KO 
ApoE/ female mice and littermate control mice 
on chow diet (A) or HFD (C); MyD88EC-KO ApoE/ 
female mice and their respective littermate con-
trols on chow diet (B) or HFD (D); and followed by 
quantitative real-time PCR and normalized to  
-actin for the indicated genes. The mean value 
of each gene in control groups on chow diet was 
set to 1. The mean value of each gene in mice on 
HFD was normalized to that in their respective 
controls on chow diet. Data are presented as 
mean ± SEM (n = 9–12 mice per genotype) and 
are representative of two independent experiments.  
(E) Protein levels of IL-1, IL-6, TNF, and CXCL1  
in the serum from MyD88MC-KO ApoE/, 
MyD88EC-KO ApoE/ female mice and their  
respective littermate controls were analyzed by 
ELISA. n = 7–9 mice per genotyping. Data are 
presented in F–J as mean ± SEM. *, P < 0.05;  
**, P < 0.01. The results are representative of  
two independent experiments.
894 MyD88 in obesity-associated inflammatory diseases | Yu et al.
metabolic syndrome, by directly impacting local and systemic 
insulin signaling and consequent long-term systemic inflam-
mation (Hotamisligil et al., 1993; Xu et al., 2003; Neels and 
Olefsky, 2006; Nishimura et al., 2009; Wajchenberg et al., 
2009). Obesity-induced adipose tissue inflammation is char-
acterized by the presence of an increased number of adipose 
tissue–infiltrating macrophages (Weisberg et al., 2003). Com-
pared with littermate controls, MyD88MC-KO mice showed 
obesity-induced inflammatory diseases, myeloid MyD88 might 
play a more dominant role in disease progression through its 
impact on systemic inflammation.
Myeloid MyD88 participates in HFD-induced  
switching of ATM from M2-like to M1-like
Metabolic-triggered inflammation in white adipose tissue plays 
a key role in initiation of inflammatory diseases associated with 
Figure 6. Deletion of MyD88 in myeloid cells and endothelial cells reduces diet-induced adipose tissue inflammation. MyD88MC-KO, MyD88EC-KO 
male mice and their respective littermate controls on HFD for 14 wk were sacrificed and epididymal fat pad was collected. (A) Paraffin sections of epididy-
mal fat pad were stained with anti-F4/80 antibody (bar, 50 µm). Arrowheads indicate F4/80+ staining; representative CLSs were enlarged and shown in 
the insert. (B) The number of CLSs was counted. Results are shown as mean ± SEM of five different sections per mouse and are representative of five mice 
per genotype with similar results. The results are representative of two independent experiments. (C and D) Total adipose tissue RNA from MyD88MC-KO, 
MyD88EC-KO, and their respective littermate control mice were analyzed by quantitative real-time PCR and normalized to -actin for the indicated genes. 
Data are presented as mean ± SEM (n = 9–11 per genotype) and are representative of two independent experiments. *, P < 0.05; **, P < 0.01. MyD88MC-KO 
ApoE/, MyD88EC-KO ApoE/ male mice and their respective littermate controls fed on either chow diet (E) or HFD (F) for 12 wk were sacrificed and epi-
didymal fat pad was collected. Total adipose tissue RNA were analyzed by quantitative real-time PCR and normalized to -actin for the indicated genes. 
Data are presented as mean ± SEM (n = 5–6 per genotype) and are representative of two independent experiments. *, P < 0.05; **, P < 0.01.
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were increased in adipose tissue of MyD88MC-KO, whereas 
M1-like marker CD11c was decreased (Fig. 6 D), which is con-
sistent with the improved adipose inflammatory status of these 
mice. When gated on CD11b+F4/80+ cells from adipose tissue 
of HFD-fed mice, the elimination of MyD88 in myeloid cells in-
creased the number of M2-like macrophages (CD11cCD206+) 
with decreased M1-like macrophages (CD11c+CD206), con-
firming the critical role of MyD88-dependent signaling in 
HFD-induced ATM switching from M2- to M1-like macro-
phages (Fig. 7 A). We then sorted for M1-like (F4/80+CD11c+) 
and M2-like (F4/80+CD206+) macrophages from adipose tissues 
of HFD-fed MyD88MC-KO and control mice, followed by gene 
expression analysis. Inflammatory gene expression (iNOS and 
IL-6) was much higher in M1-like than that in M2-like macro-
phages and substantially reduced in MyD88-deficient M1- 
and M2-like macrophages compared with their corresponding 
control macrophages, respectively (Fig. 7 B). On the other hand, 
M2-associated gene expression (Mgl1 and IL-10) was much 
higher in M2-like than that in M1-like macrophages and 
markedly reduced infiltration of macrophages and fewer so-
called crownlike structures (CLSs), which are associated with 
inflammation and apoptotic/necrotic adipocytes (Fig. 6, A, B, 
and F4/80 levels in D). In support of the histology, mRNA 
expression levels of inflammatory genes were greatly de-
creased in adipose tissue of MyD88MC-KO mice compared 
with controls (Fig. 6 C).
ATMs consist of at least two different phenotypes, classically 
activated M1-like macrophages and alternatively activated, 
resident M2-like macrophages. In obesity, infiltrating M1-like 
macrophages lead to an overall switch in adipose tissue pheno-
type, associated with insulin resistance and chronic inflammation 
(Weisberg et al., 2003; Xu et al., 2003; Lumeng et al., 2007; Zeyda 
and Stulnig, 2007; Fujisaka et al., 2009; Nguyen et al., 2007; Ohashi 
et al., 2010; Shaul et al., 2010; Zeyda et al., 2010; Prieur et al., 
2011; Sun et al., 2011; Morris et al., 2012). Interestingly, we found 
that gene markers for M2-like macrophages, including IL-10, 
C-type mannose receptor 2 (CD206), Arginase-1, and macro-
phage galactose N-acetyl-galactosamine–specific lectin 1 (Mgl-1) 
Figure 7. MyD88 participates in HFD-induced switching of ATM from M2 to M1. (A) Stromal vascular fraction (SVF) cells from epididymal fat 
pad of 6-mo-old MyD88MC-KO, MyD88EC-KO mice and their respective littermate controls on HFD were analyzed by flow cytometry. CD11b+F4/80+ (ATMs) 
were further analyzed with anti-CD11c and anti-CD206 antibodies. M1-like (F4/80+CD11c+) cells and M2-like (F4/80+CD206+) subsets were shown as 
mean ± SEM (n = 9–12 mice per genotype) and are representative of two independent experiments. *, P < 0.05; **, P < 0.01. (B) Total RNA isolated from 
M1- or M2-like macrophages was analyzed by quantitative real-time PCR and normalized to -actin for the indicated genes. The mean value of each 
gene in M1-like cells from control groups was set to 1. Data are presented as mean ± SEM (n = 5–7 per genotype) and are representative of two indepen-
dent experiments. (C) Total RNA was isolated from M1-like (F4/80+CD11c+) cells or M2-like (F4/80+CD206+) cells in aortic lesions and analyzed by quanti-
tative real-time PCR and normalized to -actin for the indicated genes. The mean value of each gene in M1-like cells from control groups was set to 1. 
Data are presented as mean ± SEM (n = 5–6 mice per genotype and are representative of two independent experiments. *, P < 0.05; **, P < 0.01.
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MyD88 in myeloid cells aborted HFD-induced switch 
of ATMs from M2- to M1-like subtype at cellular and mo-
lecular levels.
significantly increased in MyD88-deficient M2- and M1-like 
macrophages compared with their corresponding control 
macrophages (Fig. 7 B). These data indicate that deletion of 
Figure 8. Deletion of MyD88 in myeloid cells and endothelial cells prevents M1 macrophage polarization in arterial tissue under hypercholesterol-
emia. Immunostaining of atherosclerotic lesions from MyD88MC-KO ApoE/, MyD88EC-KO ApoE/ female mice and their respective littermate controls on chow 
diet (A) or HFD (B) for 3 mo. Macrophages were identified as F4/80+ (red) cells. Co-expression of F4/80 and iNOS (green) or Arg1 (green) was identified by image 
overlay. (inset) Magnification of the zone delimited in the frame. Arrowheads indicate representative M1-like (F4/80+iNOS+) or M2-like (F4/80+Arg1+) cells. Bar, 20 µm. 
n = 4–5 mice per genotype. The results are representative of three independent experiments. (C) Lesional macrophage content as determined by percentage of 
F4/80+ staining area (mean ± SEM). (D) Enumeration of M1- or M2-like macrophages by immunofluorescence in aortic root sections as shown in G. Results are 
shown as mean ± SEM of five different sections per mouse and are representative of 4–5 mice per genotype with similar results. *, P < 0.05; **, P < 0.01.
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Similar M1- and M2-associated gene expression patterns 
were observed in adipose tissues of mice bred onto ApoE/ 
background fed on HFD (Fig. 6, E and F). It is interesting to note 
that MyD88 deficiency in myeloid cells also led to a shift from 
M1-associated [iNOS; TNF, IL-1, and IL-6] to M2-like [Arg1 
and IL-10] gene expression in arterial tissue of chow- and HFD-
fed mice (Fig. 5, A and C). This finding was confirmed by im-
munostaining of sections of aortic roots of MyD88MC-KO mice 
and littermate control mice on both chow diet and HFD (Fig. 8, 
A–D). MyD88 deficiency in myeloid cells indeed led to a shift 
from M1-like (F4/80+iNOS+) to M2-like (F4/80+Arginase1+) 
macrophages in the aortic lesions of mice on chow diet or HFD 
(Fig. 8, A–D). This result was further corroborated by gene 
expression profile from sorted macrophages from aortic tissues 
of HFD-fed mice. Inflammatory gene expression (iNOS and 
IL-6) was substantially reduced in sorted MyD88-deficient M1- 
(F4/80+CD11c+) and M2-like (F4/80+CD206+) macrophages 
compared with their corresponding control macrophages, re-
spectively (Fig. 7 C). Importantly, M2-associated gene expres-
sion (Arg1 and IL-10) was much higher in M2-like than that in 
M1-like macrophages and significantly increased in MyD88-
deficient M2- and M1-like macrophages compared with their 
wild-type control macrophages, respectively (Fig. 7 C).
Because myeloid-derived MyD88 had a dramatic impact 
on the ATM phenotype, we set up an adipocyte-macrophage 
ex vivo co-culture system to explore the cross-talk between 
adipocytes and macrophages. BMDMs and 3T3L1 adipocytes 
were cultured in the bottom and inner wells of Boyden cham-
bers, respectively, which permitted passage of humoral factors 
between the chamber wells. Proinflammatory cytokine/che-
mokine mRNAs and proteins in the supernatant were higher 
in macrophages co-cultured with adipocytes than those in 
macrophages cultured alone (Fig. 9 A). The effects of co-
culturing were augmented by the increase of ratios of adipo-
cytes/macrophages (Fig. 9 A). Interestingly, we also found that 
Arginase-1 and CD206 (M2 markers) expression were re-
duced by co-culturing (Fig. 9 B). Furthermore, the expression 
of M1-associated genes, including IL-12a, IL-12b, IRF5, and 
NOS2 was concomitantly up-regulated by the increase of 
ratios of adipocytes/macrophages (Fig. 9 C). All these effects 
were reduced in MyD88KO BMDMs (Fig. 9, A–C), demon-
strating that MyD88 participates in the cross-talk between 
adipocytes and macrophages, which might play a critical role 
in HFD-induced switching of ATMs from M2- to M1-like 
phenotype. The next question is what the relevant ligands 
here. ATMs are exposed to high local concentrations of FFAs 
Figure 9. MyD88-dependent cross-talk between adipocytes and macrophages promotes M1 polarization. BMDMs of WT and MyD88KO male 
mice were plated in the bottom wells of Boyden chambers, with or without (indicated as M) 3T3 adipocytes in the inserts at a ratio of 1:1 or 5:1 (adipo-
cytes, BMDM cell numbers). mRNA expression levels of (A) CXCL1, IL-6, TNF, IL-1; (B) Arginase-1, CD206; (C) IL12a, IL12b, IRF5, and iNOS in the BMDMs 
were analyzed. The expression of mRNA normalized to -actin expression. The data are presented as fold induction over the levels of mRNAs in WT macro-
phages cultured alone. n = 5 wells in each group. Data represent the mean ± SEM of the results from three independent experiments. (D) Concentration 
of FFA in the supernatant was measured by ELISA (n = 5 wells in each group). Data are expressed as mean ± SEM of the results from three independent 
experiments. *, P < 0.05; **, P < 0.01.
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Figure 10. Endothelial MyD88 mediates GM-CSF production to prime M1 inflammatory macrophages. (A) Protein level of GM-CSF in whole 
aorta lysate taken from MyD88MC-KO ApoE/, MyD88EC-KO ApoE/ female mice and their respective littermate controls on chow diet or HFD for 12 wk 
beginning at 6 wk of age were analyzed by ELISA. Data are expressed as mean ± SEM (n = 5–6 per genotype) of the results from three independent ex-
periments. *, P < 0.05; **, P < 0.01. (B) Immunostaining of GM-CSF (green) in conjunction with CD31 (red) were performed for frozen sections of aortic 
roots from MyD88MC-KO ApoE/, MyD88EC-KO ApoE/ female mice and their respective littermate controls on chow diet (3 mo of age). Then the tissues 
were examined by confocal microscopy. Arrowheads indicate representative CD31+ GM-CSF+ cells (bar, 20 µm; L, lumen; A, arterial wall). Shown are 
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cells (Fig. 10 B). GM-CSF is well-known for its function in 
promoting monocyte differentiation toward M1 proinflamma-
tory macrophages (Verreck et al., 2004; Chitu and Stanley, 2006; 
Fleetwood et al., 2007; Hamilton, 2008; Kim et al., 2008; Waldo 
et al., 2008; Brochériou et al., 2011; Chinetti-Gbaguidi and 
Staels, 2011; Wolfs et al., 2011; Lacey et al., 2012). Based on our 
results and previous studies on GM-CSF, we proposed that 
MyD88-dependent signaling in endothelial cells induces the 
production of GM-CSF, which in turn primes the monocytes/
macrophages to become M1-like inflammatory macrophages.
To test this hypothesis, we need to know the relevant li-
gands for the MyD88-dependent signaling in endothelial cells. 
Ox-LDL (oxidized and related modified forms of low density 
lipoproteins) is an endogenous TLR2/4 ligand, which accumu-
lates in the vessel wall and is an emerging cardiovascular risk 
factor (Seimon et al., 2010; Su et al., 2011). ox-LDL may trig-
ger TLR signaling in macrophages and directly on endothelial 
cells. In addition to ox-LDL, the endothelium, the interface 
between vascular structures and blood, can also be activated by 
a variety of circulating inflammatory stimuli (Aird, 2007), in-
cluding TNF, IL-6, and IL-1. Therefore, the most relevant li-
gands for MyD88-dependent signaling in endothelial cells are 
ox-LDL and IL-1. Interestingly, we found that both ox-LDL 
and IL-1 can strongly induce GM-CSF expression in primary 
endothelial cells, which was completely abolished in MyD88-
deficient endothelial cells (Fig. 10 C). We wondered then 
whether GM-CSF produced by ox-LDL– and IL-1–treated 
endothelial cells is able to influence the macrophage function. 
We found that the conditioned medium from ox-LDL–treated 
wild-type endothelial cells (but not MyD88-deficient endo-
thelial cells) was able to induce GM-CSF-target gene PPBP 
(CXCL7; Brochériou et al., 2011; Chinetti-Gbaguidi and 
Staels, 2011) in CD11b+ monocytes and enhanced the expres-
sion of M1-associated genes including IL-12a, IL-12b, and 
iNOS (Fig. 10 D). Similar results were observed with IL-1–
treated endothelial cells (unpublished data). Neutralization with 
anti–GM-CSF greatly reduced the expression of PPBP and M1-
associated genes in monocytes in response to the conditioned 
medium from ox-LDL–treated endothelial cells (Fig. 10 D). 
Moreover, the conditioned medium from ox-LDL–treated 
released from enlarged adipocytes and augmented by increased 
lipolysis in obesity (Landin et al., 1990; Tsujita et al., 1995; 
Lafontan and Langin, 2009; Kosteli et al., 2010). We indeed 
detected FFA in the conditioned media of the co-culture ex-
periment of adipocytes and macrophages by ELISA (Fig. 9 D). 
This finding suggests that FFA from adipocytes might serve as 
a TLR ligand to activate macrophages in our co-culture system. 
In support of this, we found that palmitate-induced inflam-
matory gene expression was substantially reduced in MyD88-
deficient macrophages compared with that in control cells, 
while completely abolished in TLR4/ and partially impaired 
in TLR2/ macrophages, suggesting the possible role of satu-
rated fatty acids (SFAs) in promoting TLR-MyD88–dependent 
switching of ATMs from M2- to M1-like inflammatory mac-
rophages (unpublished data).
Endothelial MyD88 mediates GM-CSF production  
to prime M1-like inflammatory macrophages
Interestingly, MyD88EC-KO mice also showed moderate reduc-
tion in HFD-induced M1-like macrophages in adipose tissue 
(Fig. 6, C and D and Fig. 7, A and B). Endothelial-specific 
MyD88 deficiency consistently and substantially rescued insu-
lin signaling in adipose tissue (Fig. 3, E and H). Furthermore, 
MyD88 deficiency in endothelial cells (MyD88EC-KOApoE/) 
showed substantial reduction in lesion areas, aortic wall inflam-
mation (including a shift from M1- to M2-like macrophages), 
and improved insulin sensitivity of aortas in both chow and 
HFD-fed mice (Fig. 4, B, D, and E; Fig. 5, B and D; Fig. 7 C; 
and Fig. 8, A–D). Based on these results, we hypothesized that 
MyD88 signaling in endothelial cells mediates the cross-talk 
with macrophages to impact on the initiation of atherosclerosis 
and diet-induced exacerbation on atherosclerotic lesions. Inter-
estingly, we noticed that the expression of GM-CSF was sub-
stantially decreased in the arterial tissue and adipose tissue of 
MyD88EC-KO mice compared with controls (Fig. 5, B and D; 
Fig. 6 C; and Fig. 10 A). Immunostaining showed that 
GM-CSF was indeed colocalized with CD31+ endothelial cells 
in the aortic root lesions of ConEC-KOApoE/ mice, which was 
abated in that of the MyD88EC-KOApoE/ mice, demonstrat-
ing MyD88-dependent GM-CSF expression in endothelial 
representative of five mice per genotype with similar results. (C) WT and MyD88-deficient (MyD88KO) primary aortic endothelial cells (ECs) were treated 
with ox-LDL (100 µg/ml) or IL-1 (1 ng/ml) for the indicated times (time 0 were treated with native LDL). Protein levels of GM-CSF in supernatant from 
cells treated for 24 h were analyzed by ELISA. The levels of GM-CSF mRNA were measured by real-time PCR and presented as fold induction over the 
expression of WT cells at time 0. (D) WT and MyD88 KO ECs were treated with ox-LDL for 24 h, and then changed into fresh medium. After 48 h, the me-
dium was collected and used to culture sorted CD11b+ splenic monocytes for 24 h with or without anti–GM-CSF neutralizing antibody (conditioned me-
dium, conditioned medium + anti–GM-CSF). Monocytes were cultured in normal medium as negative control (vehicle). Monocytes in normal medium 
were treated with 50 ng/ml recombinant GM-CSF alone as positive control (GM-CSF). Total RNA of monocytes was subjected to real-time PCR to measure 
the relative expression of CD11c, CD206, IL-12a, IL12b, iNOS, and PPBP. The fold induction was calculated as compared with vehicle group. (E) BD-derived 
cells were cultured in DMEM supplemented with 20% FBS and 20 ng/ml GM-CSF or 50 ng/ml M-CSF for 7 d, followed by treatment of ox-LDL and FFA 
(16:0; Palmitate, 5 µM) as indicated. Total RNA was subjected to real-time PCR to measure the expression of IL-12a, IL-12b, iNOS, and PPBP. The fold in-
duction was calculated as compared with the cells primed by M-CSF at time 0. (F) BMDMs of WT male mice primed by either M-CSF or GM-CSF were 
plated in the bottom wells of Boyden chambers, with or without 3T3 adipocytes in the inserts at a ratio of 5:1 (adipocytes, BMDMs cell numbers). mRNA 
expression levels of IL12a, IL12b, IRF5, and iNOS in the BMDMs were analyzed. The fold induction was calculated as compared with the cells primed by  
M-CSF and cultured alone. mRNA expression was normalized to -actin expression. (C–F) Data represent the mean ± SEM of triplicate samples from a 
single experiments, and all results are representative of three independent experiments. *, P < 0.05; **, P < 0.01.
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effect on systemic inflammation, selectively restoring insulin 
sensitivity in adipose tissue. Whereas both myeloid- and 
endothelial-derived MyD88 were equally critical for the ini-
tiation of atherosclerosis in chow-fed ApoE-deficient mice, 
myeloid MyD88 clearly plays a more critical role than endo-
thelial MyD88 in HFD-induced atherosclerosis. Collectively, 
these results for the first time demonstrate the nonredundant 
role of MyD88-dependent signaling in myeloid and endothe-
lial cells for the development and progression of atherosclero-
sis and metabolic inflammatory diseases.
The participation of macrophages and endothelium in 
atherosclerosis has been extensively studied. In this study, we 
found that MyD88 deficiency in endothelial or myeloid cells 
inhibited vascular lesion formation in chow-fed ApoE-deficient 
mice, with similar reduction in atherosclerotic area (60–70%). 
It is interesting to note that MyD88-dependent pathology in 
chow-fed ApoE-deficient mice is restricted to the aorta, be-
cause under chow diet ApoE deficiency does not influence 
myeloid or endothelial MyD88-dependent WAT macrophage 
abundance, polarization, or inflammatory cytokine produc-
tion. These results clearly indicate the critical role of the 
MyD88-dependent pathway in the interplay between the en-
dothelium and macrophages in the aortic tissue during the 
initiation of atherosclerosis. The key initiating event in ath-
erosclerosis is retention and oxidation of LDL in the vascular 
wall (Staels, 2002). Our study suggests that endothelial cell 
activation by ox-LDL through the TLR-MyD88-dependent 
pathway probably plays an important role in the initiation 
of atherosclerosis. Although ox-LDL strongly induces the ex-
pression of GM-CSF in a MyD88-dependent manner in en-
dothelial cells, the expression of GM-CSF was greatly reduced 
in the arterial tissue of the chow-fed MyD88EC-KOApoE/ 
mice compared with that in the control mice. GM-CSF was 
indeed detected in endothelial cells of atherosclerotic lesions, 
which was abolished in the MyD88EC-KOApoE/ mice. Fur-
thermore, ox-LDL–induced expression of M1-associated genes 
was more robust in GM-CSF-primed macrophages than 
that in M-CSF-primed macrophages. Therefore, MyD88-
dependent GM-CSF production from endothelial cells might 
serve as an important link between endothelial cells and mac-
rophages by promoting M1-like inflammatory macrophages. 
In support of this, GM-CSF has been shown to be important 
in plaque development. Using the hypercholesterolemic 
ApoE/ mouse, it was found that GM-CSF treatment re-
sulted in increased atherosclerotic lesion extent (Haghighat 
et al., 2007; Shaposhnik et al., 2007). LDLR-null mice have 
been used in a study that combined 5-bromo-2-deoxyuridine 
pulse labeling with en face immunoconfocal microscopy 
to demonstrate that systemic injection of GM-CSF mark-
edly increased intimal cell proliferation (including dendritic 
cells), whereas functional GM-CSF blockade inhibited pro-
liferation(Zhu et al., 2009). Therefore, in addition to macro-
phage polarization, the impact of GM-CSF on dendritic cell 
proliferation may also contribute to the reduced lesions in 
our endothelial cell-MyD88–deficient mice. Future studies 
using cell type–specific GM-CSF receptor knockout mice 
wild-type endothelial cells (but not MyD88-deficient endo-
thelial cells) was able to increase the ratio of CD11c (M1) to 
CD206 (M2), which was also blocked by anti–GM-CSF, sup-
porting the role of GM-CSF in monocyte differentiation to-
ward M1-like macrophages (Fig. 10 D). It is important to note 
that ox-LDL used in this study was generated by using MPO/
H2O2/Nitrite system (see Materials and methods). We found 
that the ox-LDL generated by this protocol can consistently 
activate TLR-induced inflammatory genes and synergize with 
GM-CSF for up-regulation of M1-associated genes (Hazen 
et al., 1996; Hamilton et al., 1999; Hazen et al., 1999; Hazen 
and Heinecke, 1997; Febbraio et al., 2000; Podrez et al., 2000; 
Zhang et al., 2001; Baldus et al., 2003; Vita et al., 2004; 
Gallardo-Soler et al., 2008; van Tits et al., 2011).
Because ox-LDL has been shown to directly act on mac-
rophages in vivo (Nagy et al., 1998; Fischer et al., 2002; Itabe 
et al., 2011; Rios et al., 2012), we wondered whether it is pos-
sible that GM-CSF produced by ox-LDL–activated endothe-
lial cells synergizes with SFAs and ox-LDL to further promote 
M1-like proinflammatory macrophages. Palmitate and ox-
LDL indeed enhanced the expression of M1-associated genes 
in GM-CSF–primed macrophages as compared with that in 
M-CSF–primed macrophages (Fig. 10 E). Interestingly, the 
expression of M1-associated gene expression was more robustly 
enhanced in the adipocyte–macrophage ex vivo co-culture 
system when using GM-CSF–primed macrophages as com-
pared with that of M-CSF–primed macrophages (Fig. 10 F). 
Collectively, these results suggest a potential role of GM-CSF 
in priming ATMs to become M1-like macrophages during 
their cross-talk with adipocytes. It is important to note that 
endothelial-specific MyD88 deficiency substantially reduced 
HFD-induced GM-CSF expression in adipose tissue (Fig. 6 C), 
which was correlated with selective rescue of insulin signaling in 
adipose tissue of HFD-fed MyD88EC-KO mice (Fig. 3, E and H). 
These findings implicate the MyD88-dependent involvement 
of endothelial cells in the cross-talk between adipocytes and 
macrophages, which might be important for the initiation of 
obesity-associated inflammatory diseases. In support of this, 
endothelial MyD88 deficiency improved insulin sensitivity 
more dramatically at early phase (6 wk) compared to after 
3 mo of HFD (Fig. 2, C and D); and MyD88EC-KOApoE/ 
mice showed greater reduction in atherosclerotic lesions de-
veloped under chow diet (70% reduction) than under HFD 
(40% reduction).
DISCUSSION
The study presented here aimed to address how TLR signal-
ing in different cellular compartments contributes to the ini-
tiation and pathogenesis of obesity-associated inflammatory 
diseases through the specific deletion of MyD88 in endothe-
lial cells or myeloid cells. MyD88 deficiency in myeloid cells 
ameliorated diet-induced systemic inflammation and global 
insulin resistance, preserving insulin sensitivity in all the tested 
tissues including muscle, liver, and adipose tissue. On the other 
hand, endothelial-specific deficiency of MyD88 improved 
diet-induced insulin resistance at early phase with moderate 
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mice with LysMCre mice to delete MyD88 in macrophages. 
Preliminary data from LysMCreMyD88fl/fl mice showed sim-
ilar results with that in MyD88MC-KO mice as compared with 
the littermate controls (unpublished data).
Interestingly, MyD88EC-KO mice also showed moderate re-
duction in macrophage infiltration, M2- to M1-like switching, 
and adipose expression of those proinflammatory cytokine and 
chemokine genes. Whereas FFAs released from adipocytes 
might directly act on endothelial cells, IL-1 released from FFA-
induced M1-like macrophages could also activate endothelium 
through a paracrine manner. Although IL-1 strongly induced 
the expression of GM-CSF, the GM-CSF levels were substan-
tially reduced in adipose tissue of HFD-fed MyD88EC-KO mice. 
IL-1–induced GM-CSF in endothelial cells was able to pro-
mote M1-like inflammatory macrophages. Furthermore, the 
expression of M1-associated gene expression was more robustly 
enhanced in the adipocyte-macrophage ex vivo co-culture sys-
tem when using GM-CSF–primed macrophages as compared 
with that of M-CSF–primed macrophages. Thus, endothelial 
MyD88 might impact on switching of ATMs from M2- to 
M1-like through the production of GM-CSF, which may ac-
count for the selective rescue of insulin sensitivity in adipose 
tissue of HFD-fed MyD88EC-KO mice. In support of this, en-
dothelial deletion of MyD88 also moderately reduced M1-
like macrophages in the aortas, with substantial reduction of 
GM-CSF expression, which correlated with improved insulin 
sensitivity of aortic tissues from HFD-fed MyD88EC-KO mice. 
It is important to mention that the GM-CSF levels were 
not significantly reduced in liver and muscle of HFD-fed 
MyD88EC-KO mice (unpublished data), which might explain 
why these two tissues remain insulin insensitive in HFD-fed 
MyD88EC-KO mice.
It is important to note that in addition to MyD88, TLR4 
also utilizes TRIF to mediate NF-B activation to up-regulate 
inflammatory gene expression. TRIF deficiency (Lundberg 
et al., 2013) or TRIFLPS2 lack-of-function mutation were shown 
to be atheroprotective in hyperlipidemic LDL receptor knock-
out (LDLr/) mice (Richards et al., 2013). Both studies sup-
ported a critical role of TRIF-dependent pathway in the 
pathogenesis of atherosclerosis. However, it is important to 
point out that TLR4 specifically utilizes TRIF to mediate 
the activation of transcription factor IRF3 to up-regulate type 1 
IFN production, which in turn impacts on IL-10 production 
(Petrasek et al., 2011). Furthermore, it was reported that TRIF 
is not required for TLR4 signaling in endothelial cells (Harari 
et al., 2006), which was confirmed by our own studies in pri-
mary aortic vascular endothelial cells (unpublished data). There-
fore, mice with cell type–specific TRIF deletion will be critical 
reagents for future studies to compare the molecular and cellu-
lar mechanisms by which MyD88- versus TRIF-dependent 
pathway contributes to the development and pathogenesis 
obesity-associated inflammatory diseases.
In summary, this study has demonstrated that MyD88-
dependent signaling in both myeloid and endothelial cells con-
tributed to the initiation/progression of atherosclerosis and the 
development and pathogenesis of HFD-induced inflammatory 
will be required to clarify the pathogenic role of GM-CSF 
in atherosclerosis.
Interestingly, when the mice were fed the HFD, there was a 
dramatic reduction (70%) in atherosclerotic area in MyD88MC-KO  
ApoE/ mice, but a more moderate reduction (40%) in 
MyD88EC-KO ApoE/ mice. The question is why myeloid 
MyD88 plays a more critical role than endothelial MyD88 
in HFD-induced atherosclerosis. It is important to note that 
myeloid MyD88 deficiency led to greater improvement in 
HFD-induced systemic inflammation (circulating TNF, IL-6, 
and IL-1) and global insulin resistance than that by endothelial-
specific MyD88 deficiency. Under HFD-induced systemic in-
flammation, in addition to ox-LDL, the endothelium can also 
be activated by a variety of circulating inflammatory stimuli 
(Aird, 2007), including TNF and IL-6. As a result, the activation 
of endothelium, the interface between vascular structures and 
blood, becomes less dependent on the MyD88-dependent 
pathway over the course of HFD. Consistently, endothelial 
MyD88 deficiency improved global insulin resistance more 
dramatically at early phase (6 wk after HFD) than that after 
3 mo of HFD.
One important question is how systemic inflammation is 
initiated in a HFD setting. Previous studies have suggested 
that metabolically triggered inflammation in white adipose 
tissue plays a key role in the initiation of metabolic syndrome 
(Hotamisligil et al., 1993; Neels and Olefsky, 2006; Nishimura 
et al., 2009; Wajchenberg et al., 2009). ATMs are exposed to 
high local concentrations of FFAs released from adipocytes in 
obesity, and these serve as important activating ligands for 
TLR4 and TLR2 signaling in macrophages (Tsujita et al., 
1995; Suganami et al., 2005, 2007; Nguyen et al., 2007; 
Miyazaki et al., 2011; Prieur et al., 2011). The results from our 
co-culture model suggest that MyD88 participates in the 
cross-talk between adipocytes and macrophages and FFA re-
leased by adipocytes might be one of the initial ligands for 
TLR-MyD88 in this cross-talk. The cytokines (e.g., IL-1 and 
IL-6) may feedback on adipocytes to further promote this 
cross-talk (Rotter et al., 2003; Trujillo et al., 2004; Lagathu et al., 
2006; Jager et al., 2007; Stienstra et al., 2010). Compared with 
controls, MyD88MC-KO mice consistently showed markedly 
reduced infiltration of macrophages and decreased adipose 
expression of inflammatory genes. Furthermore, the elimina-
tion of MyD88 in myeloid cells increased the number of 
M2-like macrophages (CD11cCD206+), with decreased 
M1-like macrophages (CD11c+CD206) in the adipose tis-
sue, confirming the critical role of MyD88-dependent signal-
ing in HFD-induced ATM switching from M2- to M1-like 
macrophages. Myeloid-specific MyD88-dependent switch of 
ATMs from M2-like to M1-like might play a key role in the 
initiation of obesity-associated inflammatory diseases. How-
ever, it is important to note that in addition to adipose tissue, 
myeloid-specific MyD88 deficiency also preserved insulin 
sensitivity in liver and muscle, which probably contributes to 
the improvement of HFD-induced global insulin resistance 
and systemic inflammation. Because CD11bCre mediates dele-
tion of floxed sequences in myeloid cells, we crossed MyD88fl/fl 
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free; 1 mM EDTA). Splenocytes were subsequently sorted on a Dako MoFlo. 
Postsort analysis confirmed purity of 96% and viability of 95%.
Biological reagents and cell culture. Human low-density lipoprotein 
(LDL, 1.019 < density < 1.063) was isolated from plasma of normolipidemic 
donors by sequential ultracentrifugation. Native and modified LDL prepara-
tions were tested for possible endotoxin contamination using a Limulus ame-
bocyte lysate kit (Cambrex). ox-LDL was prepared by incubating LDL (0.2 mg 
protein/ml) at 37°C in 50 mM sodium phosphate, pH 7.0, 100 mM DTPA 
(diethylene-triamine-pentaacetic acid) in the presence of 30 nM myeloper-
oxidase, 100 mg/ml glucose, 20 ng/ml glucose oxidase (grade II; Boehringer 
Mannheim Biochemicals), and 0.5 mM NaNO2 for 8 h unless otherwise 
specified. Preliminary studies demonstrated that under these conditions, a 
constant flux of H2O2 (0.18 mM/min) is generated by the glucose oxidase 
system. Unless otherwise stated, oxidation reactions were terminated by ad-
dition of 40 mM butylated hydroxytoluene (100 mM ethanolic stock) and 
300 nM catalase to the reaction mixture (Abu-Soud and Hazen, 2000a,b). 
FFA solutions were prepared as described previously (Karaskov et al., 2006). 
In brief, 100-mM palmitate (Sigma-Aldrich) stocks were prepared in 0.1 M 
NaOH at 70°C and filtered. 5% (wt/vol) FFA-free BSA (Sigma-Aldrich) so-
lution was prepared in double-distilled H2O and filtered. A 5-mM FFA/5% 
BSA solution was prepared by complexing an appropriate amount of FFA to 
5% BSA in a 60°C water bath. The aforementioned solution was then cooled 
to room temperature and diluted 1:5 in RPMI 1640 without FBS to a final 
concentration of 1 mM FFA/1% BSA. Antibodies against MyD88, -actin, 
and phosphotyrosine (PY20) were purchased from Santa Cruz Biotechnol-
ogy. Antibodies against p85-PI3K, GM-CSF, M-CSF and AKT were purchased 
from Abcam. Anti-Insulin receptor substrate 1 (IRS1) antibody was pur-
chased from Upstate Biotechnology. Anti-phospho-Akt (Ser473) antibody, 
anti-arginase 1, and anti-iNOS were purchased from Cell Signaling Technol-
ogy. Anti-F4/80 was purchase from Ab Serotec. 3T3 L1 preadipocytes were 
cultured in DMEM, 10% FBS, and 1% penicillin/streptomycin, and differen-
tiated using the adipogenesis kit at 37°C and 5% CO2 (Cayman Chemical). 
Differentiation was initiated 1 d after 100% confluence was reached. Conflu-
ent 3T3-L1 cells preadipocytes were treated with 50 ml initiation medium 
containing 500 µM IBMX, 10 µM dexamethasone, 10 µg/ml insulin in 
DMEM/10% FBS for 2 d. Afterward, medium was changed to 40 ml pro-
gression medium consisting of DMEM/10% FBS supplemented with 10 µg/ml 
insulin. The 3T3-L1 cells were incubated with progression medium for 2 d. 
Subsequently, medium was changed at day 6 into 50 ml fresh DMEM/10% 
FBS, followed by another 2 d incubation at 37°C. 8 d after the initiation of 
differentiation, 3T3-L1 cells were ready for co-culture experiments. Preadi-
pocytes were only differentiated and used before passage 12, and >95% of 
cells displayed the fully differentiated phenotype. For the co-culture system, 
differentiated 3T3-L1 adipocytes were co-cultured with differentiated 
BMDMs in DMEM/10% FBS for a maximum of 24 h using 6-well plates 
containing Transwell inserts with a 0.4 m2 porous membrane (Falcon). 1 × 
104 BMDMs were seeded on the bottom of the well, whereas 1 × 104 or 5 × 
104 3T3-L1 adipocytes were seeded with into the insert. BMDMs cultured 
in the well without adipocytes seeded were set as control culture. After 24 h 
of incubation, supernatants were collected and centrifuged for 10 min at 
10,000 g and 4°C; samples were stored at 20°C for cytokines measurement. 
mRNA was collected from BMDMs for further gene expression analysis.
GTT/Insulin tolerance test (ITT). GTTs were performed by i.p. injec-
tion of 2 g/kg body weight of dextrose (Abbott Laboratories) after overnight 
fast. For ITTs, mice were injected with insulin (1 mU/g BW; Sigma-Aldrich) i.p. 
after 3-h fasting. Blood samples were obtained at 0, 15, 30, 60, 90, and 120 min 
time points and glucose levels were measured with an ultra-one glucometer.
Insulin signaling analysis. Epididymal fat, liver, and quadriceps muscle 
were collected from mice in the basal state or 5 min after an i.p. injection of 
insulin (25 mU/kg), and quickly frozen in liquid nitrogen. Frozen tissues 
were homogenized on ice in a Triton-containing lysis buffer (0.5% Triton 
X-100, 20 mM Hepes, pH 7.4, 150 mM NaCl, 12.5 mM -glycerophosphate, 
diseases. Both myeloid- and endothelial-derived MyD88 are 
critical for the initiation of atherosclerosis in chow-fed mice. 
One possible mechanism is that ox-LDL activates endothelial 
cells to produce GM-CSF, which in turn primes the mono-
cytes in the arterial tissues and synergizes with ox-LDL to pro-
mote M1 inflammatory macrophages. On the other hand, 
MyD88-dependent signaling in myeloid cells makes a greater 
contribution to the development of HFD-induced systemic 
inflammation and consequent exacerbation on atherosclerosis. 
FFAs released from adipocytes act on ATMs to promote HFD-
induced switching of ATMs from M2-like to M1-like, resulting 
in systemic inflammation and aggravating atherosclerotic le-
sions. Nevertheless, endothelial-derived MyD88 still has a no-
ticeable contribution to the diet-induced inflammatory diseases, 
possibly also through the production of GM-CSF to feedback 
on macrophages. Future studies are required to elucidate how 
the cell type–specific, MyD88-mediated signaling events con-
tribute to the cross-talks among adipocytes, macrophages, and 
endothelial cells to establish the diet-induced inflammatory 
state, leading to inflammatory diseases associated with meta-
bolic syndrome.
MATERIALS AND METHODS
Animals. CD11bCre transgenic mice were provided by G. Kollias (Bio-
medical Sciences Research Centre “Alexander Fleming,” Vari, Greece; Boillée 
et al., 2006). Tie2eCre transgenic mice were a gift of X.-Y. Fu (National 
University of Singapore, Singapore; Kano et al., 2003). MyD88 flox mice 
were provided by A. DeFranco (University of California, San Francisco, CA; 
Hou et al., 2008). All these transgenic mice used backcrossed 10 times to 
C57/BL6 background. ApoE/ mice in the C57/BL6 background were 
purchased from The Jackson Laboratory. Mice were housed in a specific 
pathogen–free facility (12-h light/dark cycle) and were fed either standard 
rodent chow or a Western style HFD ( Harlan Teklad 88137; Tordjman et al., 
2001; Chen et al., 2005; Alkhouri et al., 2010; Fernández-Real et al., 2011). 
Animals were fasted overnight and blood samples were taken for assessment 
of insulin (Crystal Chem), FFA(Cayman), cholesterol (Sigma-Aldrich), tri-
glycerides (Sigma-Aldrich) and IL-1, IL-6, TNF, CXCL1 (R&D Systems) 
levels according to manufacturer’s instructions. All experimental procedures 
were performed with the approval of the Institutional Animal Care and Use 
Committee of Cleveland Clinic (Cleveland, OH).
Primary cell isolation. BM-derived macrophages (BMDMs) were differ-
entiated from BD flushed from the tibia and femur of mice using DMEM. 
The cells were cultured in DMEM supplemented with 20% FBS and 30% 
L929 supernatant for 5 d. Mouse aortic endothelial cells (MAVECs) were 
harvested from mouse aorta under sterile conditions as previously described 
(Hatley et al., 2003). The aorta was excised; all periadventitial fat was re-
moved, and the aortic pieces were placed onto Matrigel in DMEM plus 15% 
heat-inactivated FBS following the methods outlined by Shi et al. (2000). 
After 3 d, the aortic explants were removed, and the endothelial cells were al-
lowed to grow in DMEM plus 15% heat-inactivated FBS supplemented with 
180 µg/ml heparin and 20 µg/ml endothelial cell growth supplement. At 
confluence, the cells were passaged using dispase, and then cultured for 2 d in 
DMEM plus 15% heat-inactivated FBS containing D-valine to eliminate 
possible fibroblast contamination. After 2 d, the EC were returned to growth 
medium without D-valine and allowed to grow to confluence. Mouse endo-
thelial cell cultures were used in experiments from passages 2–4. Spleens were 
minced and digested with Liberase Blendzyme 2 for 15 min in PBS at 21°C, 
passed through a 40-mm cell strainer, treated with ACK Buffer (Lonza) to 
remove red cells, and resuspended in PBE (PBS with 0.5% BSA, endotoxin 
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Mix (Applied Biosystems). PCR amplification was performed in triplicate, 
and water was used to replace cDNA in each run as a negative control. The 
reaction protocol included preincubation at 95°C to activate FastStart DNA 
polymerase for 10 min, 40 cycles of amplification beginning with 15 s of de-
naturation at 95°C, followed by annealing/extension for 60 s at 60°C. The 
results were normalized to the housekeeping gene mouse -actin. Primer se-
quences were designed using online tools from GeneScript. The primer se-
quences used will be distributed upon request.
Statistical analysis. Data are expressed as mean ± SEM. Differences were 
analyzed by Student t test and one-way ANOVA. P ≤ 0.05 was consid-
ered significant.
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